Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: DGX

Quest Diagnostics Incorporated

Healthcare | Medical - Diagnostics & Research

Market prices for DGX are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$9.42

Quest Diagnostics Incorporated (NYSE: DGX) is a diagnostics and research company. Figures from SEC EDGAR; updated 2026-10-19 20:43 UTC.

What Quest Diagnostics Incorporated does

Quest Diagnostics provides laboratory testing and diagnostic insights to multiple customers across the healthcare system, including physicians, hospitals, patients, health plans, and employers. The company operates through laboratories, patient service centers, and offices across the United States and selected international locations, serving a substantial portion of the American adult population annually.

Summarized from Quest Diagnostics Incorporated’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$9.42
Return on equity13.84%
Debt/equity0.75

Revenue, margins & earnings

FY2021 Net income: $2.00BFY2021 Taxes & interest: $386MFY2021 Operating costs: $8.41B$10.8BFY2021FY2022 Net income: $946MFY2022 Taxes & interest: $482MFY2022 Operating costs: $8.46B$9.88BFY2022FY2023 Net income: $854MFY2023 Taxes & interest: $408MFY2023 Operating costs: $7.99B$9.25BFY2023FY2024 Net income: $871MFY2024 Taxes & interest: $475MFY2024 Operating costs: $8.53B$9.87BFY2024FY2025 Net income: $992MFY2025 Taxes & interest: $564MFY2025 Operating costs: $9.48B$11.0BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-02
  • 2026-10-02DirectorPhantom Stock UnitsAward135—
  • 2026-09-03CEO and PresidentSale-10,000$2.43M
  • 2026-08-31SVP & General CounselNon-Qualifed Stock Option (right to buy)Option exercise-22,677$2.54M
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Quest Diagnostics Incorporated do?

Quest Diagnostics provides laboratory testing and diagnostic insights to multiple customers across the healthcare system, including physicians, hospitals, patients, health plans, and employers.

When did DGX last file with the SEC?

Quest Diagnostics Incorporated's most recent SEC filing on record is a 8-K filed 2026-05-21. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-19 20:43 UTC. This page is also available as JSON at /api/data?ticker=DGX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for DGX and 5,000+ tickers.

Create a free account — keep DGX
For your agent
GET /api/data?ticker=DGX

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt